Valores de corte ótimos do índice de massa corporal, circunferência abdominal e HOMA-IR para a identificação de um conjunto de anormalidades cardiometabólicas em crianças e adolescentes brasileiros com tolerância normal à glicose by Rocco, Eloa R. et al.
Co
py
rig
ht
©
 A
BE
&
M
 to
do
s o
s d
ire
ito
s r
es
er
va
do
s.
Arq Bras Endocrinol Metab. 2011;55/8638
original article
1 Endocrinology Division
and Diabetes Center, Universidade 
Federal de São Paulo (Unifesp), 
São Paulo, SP, Brazil
2 Psicobiology Department, 
Unifesp, São Paulo, SP, Brazil
Correspondence to:
Sérgio Atala Dib
Rua Botucatu, 572, conjunto 83 
04023-062 – São Paulo, SP, Brazil
sergio.dib@unifesp.br
Received on 31/Oct/2011
Accepted on 9/Nov/2011
Optimal cutoff points for body 
mass index, waist circumference 
and HOMA-IR to identify a cluster 
of cardiometabolic abnormalities 
in normal glucose-tolerant Brazilian 
children and adolescents 
Valores de corte ótimos do índice de massa corporal, 
circunferência abdominal e HOMA-IR para a identificação de 
um conjunto de anormalidades cardiometabólicas em crianças 
e adolescentes brasileiros com tolerância normal à glicose
Eloa R. Rocco1, Denise Barretto Mory1, Carla Sanchez Bergamin1, 
Fernando Valente1, Valquíria Lopes Miranda1, Bruno Frederico 
Aguilar Calegare2, Regina Quirino Silva1, Sérgio Atala Dib1
ABSTRACT
Objective: The aim of this study was to establish the best cutoff values for waist circumference 
(WC), body mass index (BMI) and HOMA-IR (HR) to identify a cluster (≥ 3) of cardiovascular risk 
factors (CVRF) in normal glucose-tolerant (NGT) Brazilian children and adolescents. Subjects 
and methods: Cross-sectional study of 319 individuals (aged 10 to 19y) from a southern Bra-
zilian city. Gender-specific receiver-operating characteristics (ROC) curves were constructed to 
assess cutoffs values of BMI (kg/m2, WC (cm), and HR. Results: The areas under the ROC curves 
to detect a cluster of CVRF were 0.92, 0.93 and 0.68 (females), and 0.93, 0.93 and 0.89 (males), 
for WC, BMI and HR, respectively. The cutoff values were 83.0 and 80.5 cm (WC), 22.7 and 20.4 
kg/m2 (BMI), and 1.65 and 1.95 (HR), for females and males, respectively, to detect the cluster 
of CVRF. Conclusion: These values of BMI, WC-) and (HR) detected a high proportion of NGTt 
Brazilian children and adolescents with a cluster of CVRF. Arq Bras Endocrinol Metab. 2011;55(8):638-45
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RESUMO
Objetivo: O objetivo deste estudo foi estabelecer os melhores valores de corte para circunfe-
rência abdominal (CA), índice de massa corpórea (IMC) e HOMA-IR (HR) para identificação da 
concomitância de um conjunto de fatores de risco cardiovascular (≥ 3) em crianças e adolescen-
tes brasileiros com tolerância normal à glicose (TNG). Sujeitos e métodos: Estudo transversal 
realizado em uma cidade do sudeste do Brasil com 319 indivíduos de 10 a 19 anos de idade. 
Curva ROC para cada gênero foi utilizada para estabelecimento dos valores de IMC (kg/m2), CA 
(cm) e HRR. Resultados: As áreas sob as curvas ROC para detectar o conjunto de fatores car-
diovascular foram 0,92, 0,93 e 0,68 (meninas) e 0,93, 0,93 e 0,89 (meninos) para CA, IMC e HR, 
respectivamente. Os valores de corte foram 83,0 e 80,5 cm (CA), 22,7 e 20,4 kg/m2 (IMC) e 1,65 
e 1,95 (HR), para meninas e meninos, respectivamente, para detecção do grupo de fatores de 
risco cardiovascular. Conclusão: Esses valores de IMC,CA e HR detectaram uma porcentagem 
significativa de crianças e adolescentes brasileiros com TNG e elevado risco cardiovascular. Arq 
Bras Endocrinol Metab. 2011;55(8):638-45
Descritores
Crianças; adolescentes; fator de risco cardiovascular; cluster
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INTRODUCTION
The prevalence of overweight and obesity in chil-dren is increasing rapidly, and the ongoing obe-
sity epidemic represents a major public health burden 
worldwide (1,2). The prevalence of overweight among 
Brazilian adolescents has risen from 4.0% to 13.0% over 
a 20-year period (3). 
The natural history of insulin resistance (IR) may 
begin in the intrauterine life and, after birth, it may 
continue to develop as a result of the interaction between 
genetic and environmental factors. The combination of 
IR and subsequent hyperinsulinemia with a number of 
metabolic and cardiovascular risk factors (CVRF) has 
become known as metabolic syndrome (Met-S) (4). 
In a previous report of our group, we found that the 
prevalence of Met-S was 6% for the whole sample of 
adolescents, and 26.1% in the obese subgroup (5).
It has been shown that visceral adiposity is inde-
pendently associated with a cluster of CVRF compared 
to total adiposity (6-8). It is important to investigate 
when IR starts to be related with cardiometabolic ab-
normalities among adolescents, and what relationship it 
might have with waist circumference (WC).
In the last consensus for the study of IR in children 
(9), it was found that there was no justification for scre-
ening children for IR, because there are no clear criteria 
to define this condition in this age group, and that the 
two most important biological conditions associated 
with the IR were ethnicity and puberty. 
In this study, we identified the prevalence of a clus-
ter of cardiometabolic abnormalities at different levels 
of insulin resistance in a group of children and adoles-
cents with normal glucose tolerance. We also establi-
shed the best cutoff values for the HOMA-IR index, 
WC and BMI to identify normal glucose-tolerant Bra-
zilian children and adolescents with a cluster of CVRF.
RESEARCH DESIGN AND METHODS
This is a cross-sectional study of a total of 319 children 
and adolescents recruited from an elementary school 
in the metropolitan area of the city of São Paulo, SP, 
Brazil. The inclusion criteria were that subjects were 
healthy and between 10 and 19 years old. In addition, 
none of these subjects should be taking medications 
that are known to have an impact on insulin sensitivi-
ty. This study was approved by the Ethics Committee 
of the Universidade Federal de São Paulo. Informed 
consent was obtained from all participants or his/her 
parents or guardians. 
The subjects were assessed at 8 am, after a 12-h 
overnight fast. A detailed medical history was obtained 
from all subjects, including information on race, physi-
cal activity, and type 2 and gestational diabetes mellitus 
in first- or second-degree relatives. 
Anthropometric measurements were performed, 
blood pressure was measured and an intravenous an-
tecubital catheter was placed. Blood was drawn for la-
boratory at fasting for the analyses of fasting plasma 
glucose (FPG) and serum insulin, and again after 120 
min of a glucose load (1.75 g/kg, max 75 g). A phy-
sician performed the examination for Acanthosis nigri-
cans and Tanner staging (10). 
Body mass index (BMI, kg/m2) and BMI percen-
tiles were then calculated using the age and gender-
-specific percentiles of the Centers for Disease Control 
(CDC). The participants were grouped as presenting 
normal weight (BMI < 85th percentile), overweight 
(85th ≥ BMI < 95th percentile) and obese (BMI ≥ 95th 
percentile) (11).
WC was measured with a flexible tape, midway bet-
ween the lowest rib and the superior border of the iliac 
crest (12). Systolic and diastolic blood pressure was me-
asured in the right arm, in a sitting position, using a ca-
librated sphygmomanometer with appropriate cuff size, 
under standard conditions. Children whose systolic or 
diastolic blood pressure exceeded the 90th percentile for 
the age and gender were considered hypertensive (13).
Physical activity levels were assessed using the In-
ternational Physical Activity Questionnaire (IPAQ-8, 
short version). IPAQ is a questionnaire made available 
by the WHO for assessing physical activity worldwi-
de and it is currently in use in 12 countries (14). This 
questionnaire includes questions about the duration 
and intensity of physical activity during a “usual” week, 
in occupational, transport, leisure, or sports activities.
The American Diabetes Association criteria (ADA, 
2009) were used for glucose tolerance classification 
(15). The homeostasis model of insulin resistance 
(HOMA-IR) index and β-cell function (HOMA-B) 
were calculated using the HOMA model software 
(University of Oxford, Oxford, UK) (16).
The HOMA-IR index from a subgroup of 202 sub-
jects of the same age and gender of the studied popula-
tion with normal BMI and glucose tolerance were cate-
gorized in the percentiles 5 to 25, 25 to 50, 50 to 85, 
85 to 95 and > 95, and ranged from 0.4 to 0.8, 0.81 to 
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1.2, 1.21 to 2.0, 2.1 to 2.92 and > 2.93, respectively, 
as a normal distribution. 
Abdominal obesity (≥ 90th percentile), hyperten-
sion (≥ 90th percentile), increased level of triglycerides 
(≥ 10 mg/dL), decreased HDL-cholesterol levels (≤ 40 
mg/dL), and hyperglycemia (≥ 100 mg/dL) were used 
as the cluster of cardiometabolic abnormalities in the 
present study. The set of three or more of these varia-
ble was known as metabolic syndrome, in accordance 
with NCEPATPIII (National Cholesterol Education 
Program’s Adult Treatment Panel III), modified for 
the age (17).
We used ROC curves to choose the cutoff points 
for BMI, HOMA-IR and WC to identify the cluster of 
cardiometabolic abnormalities in the same individual. 
We preferred to choose higher sensitivities to identify 
children with CVRF. 
BIOCHEMICAL ANALYSIS
Plasma glucose levels were determined by a glucose 
hexokinase II (Bayer ADVIA 1650 analyzer), and cho-
lesterol levels by an enzymatic method (Bayer ADVIA 
1650 analyzer). The TG method was based on the Fos-
sati three-step enzymatic reaction with a Trinder end-
point (Bayer ADVIA 1650 analyzer).
Plasma insulin was measured by Auto DELFIA 
time-resolved fluoroimmunoassay (Wallac Oy, Turku, 
Finland). The intra-assay variations (%CV) were 2.4 
and 1.7% for 5.65 and 30.2 μU/mL, respectively. The 
inter-assay variations (%CV) were 2.3 and 3.5% for the 
same insulin values shown above, respectively. Ho-
mocysteine (Hcy) was measured by means of HPLC 
for plasma total homocysteine and cysteine.
HbA1C was measured by HPLC (normal range 
3.5% – 6.0%).
STATISTICAL ANALYSIS
All values were expressed as means ± SD. Boys and 
girls were compared according to demographic, clini-
cal and laboratory characteristics using qui-square test 
or Student’s t test. Mean HOMA-IR, BMI and WC 
were compared using the Student’s t test or the Mann- 
Whitney test. The ROC curve was used to define the 
cutoff values of HOMA-IR, BMI and WC to identi-
fy the cluster of cardiometabolic abnormalities, and 
p-values lower than 0.05 were considered statistically 
significant.
RESULTS
The characteristics of the 319 children and adolescents, 
physical findings, and laboratory results are found in 
table 1. 
BMI, WC, HR values and CVRF cluster in children and adolescents
Table 1. Descriptive characteristics of children and adolescents studied
n Girls179 (56.1%)
Boys
140 (43.9%) p value
AGE (years) 13.1 ± 2.5 13.2 ± 2.4 ns
RACE
White
Non-white
75 (41.9%)
104 (58.1%)
52 (37.1%)
88 (62.9%)
ns
ns
Family history of type 2 
diabetes mellitus
104 (58.1%) 101 (72.1%) 0.013
BMI (kg/m2) 22.5 ± 5.9 21.3 ± 4.7 ns
TANNER 4.1 ± 1.2 3.2 ± 1.5 < 0.001
SBP (mmHg) 109.0 ± 14.7 108.7 ± 16.1 ns
DBP (mmHg) 66.8 ± 12.4 65.8 ± 13.2 ns
WC (cm) 76.8 ± 16.7 74.8 ± 14.6 ns
Physical activity 0.8 ± 0.8 1.6 ± 1.2 < 0.001
Birth weight (g) 3117.7 ± 635.0 3323.6 ± 739.3 0.013
Acanthosis nigricans 40 (22.3%) 17 (12.1%) 0.027
TC (mg/dL) 162.5 ± 33.7 156.5 ± 30.7 ns
HDL (mg/dL) 49.7 ± 11.7 48.5 ± 10.8 ns
LDL-C (mg/dL) 92.9 ± 25.9 91.3 ± 25.0 ns
TG (mg/dL) 98.0 ± 60.3 80.6 ± 30.3 0.018
HbA1c (%) 5.2 ± 0.3 5.4 ± 0.4 < 0.001
FPG (mg/dL) 81.3 ± 11.0 82.8 ± 9.4 0.054
2hPG (mg/dL) 86.1 ± 18.2 85.4 ± 18.1 ns
FSI (µU/mL) 14.0 ± 14.0 9.3 ± 7.4 < 0.001
HOMA-B (%) 178.0 ± 72.8 139.2 ± 75.6 < 0.001
HOMA-IR 1.7 ± 0.9 1.3 ± 1.0 < 0.001
HCY 8.8 ± 2.1 9.6 ± 2.0 0.010
There were no differences in mean age, race, BMI, 
WC, blood pressure, cholesterol levels, or 2-hour plas-
ma glucose among the gender groups. Girls tended to 
be at a higher Tanner stage (4.1 ± 1.2 vs. 3.2 ± 1.5; 
p < 0.001) and to have lower physical activity (0.8 ± 0.8 
vs. 1.6 ± 1.2; p < 0.001) than boys. Triglycerides were 
higher among the girls (98. 0 ± 60.3 mg/dL vs. 80.6 ± 
30.3 mg/dL; p = 0.018). 
Seven of the 319 subjects presented impaired fasting 
plasma glucose (IFG) (≥ 100 mg/dL and < 126 mg/
dL), but none had impaired glucose tolerance (IGT) 
(2 h-plasma glucose ≥ 140 mg/dL and < 200 mg/dL) 
in the first analysis. None of them presented confirmed 
IFG after another oral glucose tolerance test (OGTT). 
HbA1c was higher in boys than in girls (5.4 ± 0.4 vs. 
5.2 ± 0.3%; p < 0.001).
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Girls had higher fasting serum insulin (14.0 ± 14.0 
vs. 9.3 ± 7.4 µU/mL; p < 0.001), HOMA-IR (1.7 ± 
0.9 vs. 1.3 ± 1.0; p < 0.001), and higher HOMA-B 
(178.0 ± 72.8 vs. 139.2 ± 75.6; p < 0.001) than boys. 
On the other hand, boys had higher Hcy than girls (8.8 
± 2.1 vs. 9.6 ± 2.0 mmol/L; p = 0.010). 
Further, 297 individuals with complete data re-
quired for Met-S definition, were classified according 
to HOMA-IR percentiles, as shown in table 2. These 
groups did not differ significantly in relation to age, 
Tanner stage, DBP, birth weight, HbA1c, Hcy, or fa-
mily history of type 2 diabetes mellitus.
The group with lower insulin resistance (Gp5-25) pre-
sented greater prevalence of males, higher levels of phy-
sical activity (1.5 ± 1.3 vs. 0.9 ± 0.9; p = 0.047), higher 
HDL (53.4 ± 12.8 vs. 46.8 ± 15.6 mg/dL; p < 0.05), 
and lower triglycerides (69.8 ± 25.8 vs. 109.6 ± 46.0 
and 132.0 ± 108.6 mg/dL; p = 0.018). The group with 
HOMA-IR > p85 presented higher BMI, SBP, WC, to-
tal cholesterol and triglycerides. The presence of Acan-
thosis nigricans was greater in Gp>95. Triglycerides were 
higher in Gp>95 than in Gp>85-95 (132.0 ± 108.6 vs. 109.6 
± 46 mg/dL; p < 0.05).
Application of the modified ATPIII criteria to these 
groups identified Met-S in none of the Gp5-p25; 3.0% of 
the Gp25-50 ; 9.0% of the Gp50-85; 24.4% of the Gp85-95 and 
26.9% of the Gp>95. HOMA-IR > 2.1 was significantly 
associated with Met-S.
WC > 85th percentile was identified in 9.8%, 24.2%, 
30.3%, 55.5% and 53.8%; BP > 90th in 11.3%, 12.1%, 
15.7%, 31.1% and 30.8%; triglycerides > 90th percen-
tile in 7.0%, 18.2%, 19.1%, 40.0% and 42.3%; HDL 
≤ 40 mg/dL in 12.7%, 18.2%, 16.8%, 22.2% and 34.6%, 
according to HOMA-IR percentiles 5 to 25, 25 to 50, 
50 to 85, 85 to 95 and > 95, respectively, as shown in 
figure 1.
Table 2. Characteristics of subjects in different HOMA-IR percentiles 
Percentile 5 - 25 25 - 50 50 - 85 85 - 95 > 95 p
N 71 66 89 45 26
HOMA IR 0.4-0.8 0.81-1.2 1.21-2.0 2.1-2.92 > 2.93
Age (years) 13.4 ± 2.6 13.3 ± 2.4 13.2 ± 2.5 12.5 ± 2.0 12.6 ± 2.1 ns
Gender (male) 51 (71.8%) 26 (39.4%) 31 (34.8%) 13 (28.9%) 8 (30.8%) *
Family history of type 2 diabetes 45 (63.4%) 42 (63.6%) 53 (59.6%) 30 (66.7%) 15 (57.7%) ns
BMI (kg/m2) 19.6 ± 3.5 21.1 ± 3.9 21.6 ± 5.5 24.7 ± 5.6 24.8 ± 7.8 †
Tanner 3.5 ± 1.6 3.8 ± 1.3 3.7 ± 1.4 3.7 ± 1.2 3.8 ± 1.3 ns
SBP (mmHg) 105.8 ± 14.9 107.5 ± 11.4 105.2 ± 14.8 113.7 ± 12.4 113.8 ± 21.2 ‡
DBP (mmHg) 65.5 ± 12.0 64.7 ± 12.0 63.8 ± 12.6 68.4 ± 10.2 68.6 ± 14.4 ns
WC (cm) 68.9 ± 9.4 72.6 ± 11.2 75.5 ± 16.3 84.5 ± 16.1 83.0 ± 20.6 †
Physical activity 1.5 ± 1.3 1.1 ± 1.0 1.1 ± 1.1 0.9 ± 0.9 0.9 ± 0.9 §
Birth weight (g) 3321.7 ± 689.1 3199.8 ± 621.2 3166.7 ± 759.4 3164.0 ± 655.8 2943.7 ± 546.0 ns
Acanthosis nigricans 6 (8.5%) 12 (18.2%) 14 (15.7%) 7 (15.6%) 11 (42.3%) •
TC (mg/dl) 160.9 ± 30.9 163.8 ± 35.6 154.2 ± 29.4 171.1 ± 29.2 157.2 ± 40.7 ¶
HDL (mg/dl) 53.4 ± 12.8 48.6 ± 10.4 49.1 ± 10.0 47.4 ± 8.7 46.8 ± 15.6 #
LDL (mg/dl) 92.7 ± 24.3 96.3 ± 30.3 87.8 ± 23.3 101.9 ± 23.8 81.1 ± 18.4 **
TG (mg/dl) 69.8 ± 25.8 92.6 ± 46.2 86.8 ± 35.2 109.6 ± 46.0 132.0 ± 108.6 ††
HbA1c (%) 5.3 ± 0.4 5.3 ± 0.3 5.2 ± 0.4 5.3 ± 0.3 5.2 ± 0.2 ns
FPG (mg/dl) 80.1 ± 10.1 79.8 ± 8.7 82.7 ± 10.0 84.2 ± 10.9 86.4 ± 10.7  ‡
2hPG (mg/dl) 78.6 ± 15.7 85.0 ± 21.3 86.3 ± 16.9 92.0 ± 18.5 89.9 ± 15.4 ‡‡
FSI (uU/ml) 4.3 ± 1.1 7.4 ± 0.8 11.4 ± 1.8 18.0 ± 1.7 37.4 ± 26.2 §§
HOMA-B (%) 94.7 ± 29.4 133.1 ± 38.8 166.7 ± 50.9 221.6 ± 74.4 286.1 ± 90.8 §§
Hcy 9.6 ± 2.4 8.7 ± 2.0 8.9 ± 1.7 10.2 ± 2.8 8.6 ± 1.6 0.091
Met-S 0 2 (3.0%) 8 (9.0%) 11 (24.4%) 7 (26.9%) ••
* Gp5-25 vs. Gp25-50; Gp50-85 ; Gp85-95; Gp>95; p < 0.05; † Gp85-95 vs. Gp5-25; Gp25-50; Gp50-85; p < 0.05; ‡ Gp85-95 vs. Gp5-25; Gp50-85; p < 0.05; § GP5-25 vs. Gp85-95; p = 0.047; • Gp>95 vs. Gp5-25; Gp25-50; Gp50-85 ; Gp85-95; p < 0.05; 
¶ Gp85-95 vs. Gp50-85; p < 0.05; # Gp5-25 vs. Gp>95; p < 0.05; ** Gp85-95 vs. Gp50-85; Gp>95; p < 0.05; †† Gp>95 vs. Gp5-25; Gp25-50; Gp50-85 and Gp85-95 vrs Gp5-25;Gp50-85; p < 0.05; ‡‡ Gp85-95 vs. Gp5-25; p < 0.05; §§ Gp>95 vs. 
Gp5-25; Gp25-50; Gp50-85 and Gp85-95 vrs Gp5-25; Gp25-50; Gp50-85; p < 0.05; •• Gp>95 vs. Gp5-25; Gp25-50; Gp50-85 and Gp85-95 vrs Gp5-25; Gp25-50; Gp50-85; p < 0.05.
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ROC curve analysis was performed to evaluate the 
relationship between WC, BMI and HOMA-IR to 
identify the cluster of cardiometabolic abnormalities 
among these adolescents. The optimal cutoff point of 
WC, BMI and HOMA-IR as a predictor of the clus-
ter of cardiometabolic abnormalities was 80.5 cm and 
83 cm, 20.4 and 22.7 kg/m2, 1.95 and 1.65 for males 
and females, respectively. These data are illustrated in 
the figure 2, which shows the differences between the 
genders. 
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Figure 2. ROC curve analysis and cutoff values for WC, BMI and HOMA-IR to identify normal glucose-tolerant young individuals with a cluster of CVRF in 
females (A) and males (B).
Figure 1. Metabolic syndrome components (ATPIII criteria) identified through the insulin resistance (HOMA-IR) percentiles in the group of adolescents with 
normal oral glucose tolerance studied.
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DISCUSSION
The prevalence of Met-S by the age-modified ATPIII 
criteria was 8.8% in the whole group of the normal glu-
cose-tolerant Brazilian children and adolescents studied. 
However, this prevalence was 3 times higher (25%) in 
the specific group of young individuals above the 85th 
percentile of insulin resistance (HOMA-IR ≥ 2.1).
ROC curve analysis results, showed that BMI and 
WC values presented high sensitivity (99% to 100%) 
to detect the cluster of cardiometabolic abnormalities 
(≥ 3) in both genders of normal glucose-tolerant Bra-
zilian individuals. So did HOMA-IR (90% sensitivity) 
in the male subgroup. Among these three measures, 
WC showed better specificity (79.7%) to detect these 
cardiometabolic signals in these adolescents. 
On the whole, our data were similar to the findings 
from a study on 991 adolescents of similar age range 
(12-19 years old) from the National Health and Nutrition 
Examination Study (NHANES) 1999-2000, which used 
the same criteria for Met-S. In this study, the prevalence 
of Met-S was 6.4% (18), but it was higher than in ano-
ther school-based, cross-sectional study on 1513 black, 
white and Hispanic teenagers, among whom the pre-
valence of ATPIII-defined Met-S was 4.2% (19). This 
difference on prevalence could be explained by the use 
of the age-modified ATPIII criteria in our study, and 
not in the NHANES one. 
It is known that the prevalence of Met-S is associa-
ted with a degree of overweight, and it has a wide ran-
ge (6%-39%) of prevalence among normal adolescents 
when different definitions proposed for this condition 
are considered (20). In our study, Met-S prevalence 
using the age-modified ATPIII criteria was 1.3%, 4.2% 
and 48.9% among the normal, overweight and obese 
individuals, respectively. In a population-based study 
on Chinese school children, the prevalence rates of 
Met-S according to the ATPIII definition were 0.9%, 
7.6% and 29.8% among the normal weight (control 
group), overweight and obese children, respectively 
(21). Thus, based on subject’s weight, the results rela-
ted to increased prevalence of Met-S were similar, des-
pite differences in the populations.
Similar to data on adults, WC values could be used 
to identify children with Met-S, especially considering 
that references are available in the literature (12). Ho-
wever, there is no consensus, so far, on the method and 
the value to evaluate this variable in children and ado-
lescents. 
Abdominal adiposity was positioned as the sine qua 
non in the IDF definition of Met-S. Using the new IDF 
definition for Met-S in children and adolescents, we 
found a Met-S rate of 5.0% in our group of individuals, 
which was lower than the one we found (8.8%) with the 
ATPIII criteria. For normal, overweight and obese sub-
jects, respectively, the comparison between ATPIII and 
IDF showed 1.3 vs. 0%, 4.2 vs. 2.0%, and 48.9 vs. 31.9% 
(data not shown). In the Chinese study, the results 
were similar and lower than the rates obtained using 
the ATPIII definition, with 0.1%, 5.2% and 28.6% in 
these three groups (21). This lower prevalence in our 
study can be explained especially by the higher levels of 
triglycerides used in the ATPIII criteria, compared with 
the IDF definitions (150 mg/dL vs. 110 mg/dL). This 
was possibly not observed in the Chinese population. 
The characteristics of Met-S or related factors among 
adolescents also showed differences between the gen-
ders. In our study, girls presented higher insulin resis-
tance because of higher puberty stage and lower physical 
activity than boys. However, besides these two factors, 
the prevalence of Met-S was not higher in girls. Interes-
tingly, fasting plasma glucose (82.8 ± 9.4 vs. 81.3 ± 11.0 
mg/dL; p = 0.054) showed a tendency to be higher in 
boys, with lower β-cell function (HOMA-B: 139.2 ± 
75.6% vs. 178.0 ± 72.8; p < 0.001) than in girls. In spite 
of the overall lower insulin resistance in boys, they had 
higher levels of HbA1c (5.4 ± 0.4 vs. 5.2 ± 0.3%; p < 
0.001), albeit within the normal range (22).
The lower pancreatic β-cell function in boys than in 
girls may be related to lower insulin resistance and hi-
gher Hcy blood levels (8.8 ± 2.1 vs. 9.6 ± 2.0 mmol/L; 
p = 0.010) in these individuals. Previous studies have 
shown that Hcy is higher in boys, and it is independent 
of the degree of obesity (23). Must and cols. (24) stu-
died 942 boys and 1,085 girls in NHANES III, and 
showed that sexual dimorphism of Hcy concentrations 
occurs earlier, at approximately 10 years of age, whi-
ch is lower than the mean age of our group. We can 
see in table 1 that Hcy levels did not follow the in-
sulin resistance levels, showing that others factors may 
have influenced its levels. In vitro studies using clonal 
BRIN-BD 11 β-cells showed that homocysteine inhibi-
ted insulin release in a dose-dependent way at moderate 
and stimulatory glucose concentrations (25). Thus, we 
do not know if this levels of homocysteine in boys was 
influenced in their β-cell function. 
When we analyzed the prevalence of the cluster of 
cardiometabolic abnormalities at different levels of 
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insulin resistance, we saw that CVRF prevalence began to 
increase significantly after the 85th percentile of HOMA-
IR (HOMA-IR = 2.1). Above this HOMA-IR value, 
the prevalence (24.4%) of the cluster of cardiometabolic 
abnormalities in these normal glucose-tolerant young 
individuals was about 8 times higher than in groups 
with HOMA-IR below 1.2. It has been demonstrated 
that the prevalence of the cluster of cardiometabolic 
abnormalities was positively associated with the degree 
of HOMA-IR (5). However, current literature does not 
present any HOMA-IR cutoff point to classify insulin 
resistance among adolescents. Some studies have shown 
great variation in mean HOMA-IR levels (1.5-6.3), 
depending on BMI (5,26), and most of them have used 
upper tertiles or quartiles to identify insulin resistance. In 
our overall analysis, HOMA-IR was positively associated 
with body fat and WC, and it was negatively associated 
with HDL-C. These data match other findings among 
adolescents aged 12-19 years (27). Just as in adults, 
lowered HDL-C also appears to be the metabolic 
abnormality most associated with insulin resistance in 
adolescents. In our data the HDL levels were significant 
lower in the group with HOMA-IR > 2.9 than in the 
group with HOMA-IR between 0.4-0.8. In the clinical 
analyses, the prevalence of Acanthosis nigricans was 
significantly higher only with HOMA-IR ≥ 2.9. 
ROC curve analysis is a way of evaluating the accu-
racy of a diagnostic test by summarizing the potential of 
the test to discriminate between the absence and presen-
ce of a certain condition. In the context of the present 
study, this diagnostic accuracy refers to the ability of the 
anthropometric variables to identify children with the 
cluster of cardiometabolic abnormalities (≥ 3). From 
our results, WC appears to have similar effect to that of 
the BMI in screening for the cluster of cardiometabolic 
abnormalities. For males, WC = 80.5 cm, BMI = 20.4 
kg/m2 and HOMA-IR = 1.95 presented sensitivity of 
more than 90%, and specificity of more than 65.5%. For 
females, WC = 83 cm, BMI = 22.7 kg/m2 and HOMA-
-IR = 1.65 presented sensitivity of more than 70.6%, 
and specificity of 55.8%. It is important to note that 
HOMA-IR values (1.65 and 1.95) that corresponds to 
the 50th percentile of this population were lower than 
50th percentile (HOMA-IR = 3.4) of the other Latin 
(Mexican) children population (23a) and were also as-
sociated with increased prevalence of CVRF when com-
pared to the lowest percentile of HOMA-IR values. 
Although WC may be useful in estimating visceral 
fat, the reliability of WC has not been determined yet, 
especially among children and adolescents. BMI was 
an excellent parameter in the present study, and was as 
good as WC for both sexes. Among males, HOMA-IR 
was as good as WC and BM, but the same was not true 
for females.
Some limitations of the present study deserve to be 
acknowledged. First, insulin is not a worldwide stan-
dardized assay. Assessment methods differ between 
laboratories, making comparisons with other studies 
difficult. Second, the fact that HOMA-IR was used 
as a surrogate marker for insulin resistance, instead of 
using the gold standard – hyperinsulinemic euglycemic 
clamps – could be a possible source of bias. Third, this 
was a cross-sectional analysis, and therefore causal asso-
ciations could not be established. 
In conclusion, the prevalence of Met-S was 8.8% 
in the whole group of normal glucose-tolerant Brazi-
lian children and adolescents, and almost 40% among 
overweight subjects. The cluster of cardiometabolic ab-
normalities that will develop as insulin resistance with 
time is prevalent and increases significantly above 85th 
percentile in young individuals. BMI and WC were 
good predictors for the cluster of cardiometabolic ab-
normalities among children. The construction of ROC 
curves enables the identification of the best cutoff point 
at which these variables are best indicators of the car-
diovascular risk cluster.
One particular aspect to point out in relation 
to other similar studies from US and Europe is 
the absence of type 2 diabetes in the group of high 
cardiovascular risk Brazilian adolescents, so far. This 
absence may be related to the degree of obesity or to 
β-cell function. A recent study has shown that this is 
one of the principal factors differentiating between 
normal glucose tolerance, impaired glucose tolerance, 
and type 2 diabetes (28) in this age group. Therefore, 
our data point out the heterogeneity of the relationship 
between the degree of insulin resistance in children 
and adolescents and cardiometabolic abnormalities in 
different populations. 
Nonetheless, data from the present study shows that 
practice (BMI and WC) and laboratory-based (HO-
MA-IR) information, and their respective cutoff points 
may be applied to detect a cluster of cardiometabolic 
abnormalities in children and adolescents. Timely diag-
nosis is important for appropriated prevention and tre-
atment of these strong markers in order to reduce the 
associated risk of metabolic and cardiovascular disease 
in young populations. 
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